Patent · US Active

CGRP peptide antagonists and conjugates

US8168592B2 · kind B2 · utility

16Cited by

97References

11Claims

0Family size

Assignee

AMGEN INC. · US

Inventors

Colin Gegg · Newbury Park, US
Eileen J. Johnson · Newbury Park, US
Leslie P. Miranda · Thousand Oaks, US
Kenneth W. Walker · Newbury Park, US
Jerry Ryan HOLDER · Simi Valley, US
Marie E. Wright · Westlake Village, US
Derin D'Amico · Newbury Park, US

Key dates

Filing date	Oct 19, 2006
Grant date	May 1, 2012
Priority date	—
Expiry date	Oct 1, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K14/57527
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed is a composition of matter that involves a CGRP peptide antagonist. A pharmaceutical composition is disclosed that comprises the composition of matter and a pharmaceutically acceptable carrier, which can be configured for administration to a patient. Also disclosed is a method of producing the composition of matter. Methods of treating, preventing or mitigating migraine, are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.